カルシウム依存型チロシンキナーゼPYK2が,内皮の酸化窒素合成酵素媒介による血管新生反応と血管機能における中心的な役割を果たしている
Akihiro Matsui1, Mitsuhiko Okigaki, Katsuya Amano
1Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kamigyo-ku, Kyoto, 602-8566, Japan.
Circulation
|August 19, 2007
まとめ
プロリンに富んだチロシンキナーゼ2 (PYK2) は,血管の形成と機能において重要な役割を果たします. 欠乏すると,血管内皮成長因子 (VEGF) のシグナル伝達が低下し,内皮NO合成酵素 (eNOS) の活性化と血流回復に影響する.
科学分野:
- 心血管生物学 心血管生物学
- 分子生物学は分子生物学である.
- 細胞シグナル伝達 細胞信号伝達
背景:
- Akt/endothelial NO synthase (eNOS) 経路におけるカルシウム (Ca2+) 依存型チロシンキナーゼPYK2の役割は完全に理解されていません.
- PYK2の機能を理解することは,血管の健康と疾患のメカニズムを明らかにするために重要です.
研究 の 目的:
- Akt/eNOS経路におけるPYK2の関与を調査する.
- 血管内皮成長因子 (VEGF) 媒介のシグナル伝達と血管新生反応におけるPYK2の役割を決定する.
主な方法:
- PYK2ノックアウト (PYK2-/-) のマウスを利用して,後肢のイシュケミアの回復と新血管形成を評価しました.
- PYK2欠乏性大動脈内皮細胞における,Ca2+動員,Akt活性化,AMP活性化タンパク質キナーゼ/タンパク質キナーゼ-A経路を含む,VEGF媒介のシグナル伝達を調べた.
- アセチルコリン媒介の血管リラックスとcGMPの産生を評価した.
- 内皮細胞の移動,チューブ形成,アクチン細胞骨格の再編成を研究した.
- PYK2/Src複合体を用いてタンパク質の相互作用を分析し,SrcがPLCgamma1と関連し,PLCgamma1.1のリン酸化を行った.
主要な成果:
- PYK2欠乏症は,血流の回復を阻害し,不血症後の新血管形成を阻害する.
- VEGF誘発のCa2+動員とAktの活性化は,PYK2欠乏細胞で減少した.
- 大動脈の血管リラックスとcGMPの産生が著しく低下しました.
- 内皮細胞の移動,管の形成,Rac1の活性化が抑制された.
- PYK2欠乏症は,PLCgamma1とのVEGF媒介のSrc結合と,その後のリン酸化を廃止した.
結論:
- PYK2は,Src/PLCgamma1およびSrc/PI3-キナーゼ/Akt.を含むVEGFおよびイシュケミア活性化シグナル伝達経路にとって不可欠です.
- PYK2はeNOSのリン酸化を調節し,それによってeNOS媒介の血管活性機能と血管新生反応に影響を与えます.
- これらの発見は,PYK2が血管機能と血管新生の重要な調節因子であることを強調しています.
関連する概念動画
Mechanism of Angiogenesis
6.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.4K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Receptor Tyrosine Kinases
15.6K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
15.6K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
Transducer Mechanism: Enzyme-Linked Receptors
4.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
4.4K


